Evidence map›Paper›PMID 30043824›Full record

Observational studyClinics (Sao Paulo, Brazil)2018

Measuring herpes zoster disease burden in São Paulo, Brazil: a clinico-epidemiological single-center study.

João Toniolo-Neto, Eliofotisti Psaradellis, Angela Karellis, Emmanouil Rampakakis, Talita Y Rockett, John S Sampalis, Kelly D Johnson, Homero A Monsanto, Camilo J Acosta

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Clinics (Sao Paulo, Brazil), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. Observational
  8. Epidemiology and clinical characteristics of herpes zoster in a tertiary care hospital in Brazil.The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases
    Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

João Toniolo-NetoNucleo de Pesquisas Clinicas e Envelhecimento (NUPEQ), Universidade Federal de Sao Paulo - Escola Paulista de Medicina (Unifesp-EPM), Sao Paulo, SP, BR.
Eliofotisti PsaradellisJSS Medical Research Inc., St-Laurent, QC, Canada.
Angela KarellisJSS Medical Research Inc., St-Laurent, QC, Canada.
Emmanouil RampakakisJSS Medical Research Inc., St-Laurent, QC, Canada.
Talita Y RockettNucleo de Pesquisas Clinicas e Envelhecimento (NUPEQ), Universidade Federal de Sao Paulo - Escola Paulista de Medicina (Unifesp-EPM), Sao Paulo, SP, BR.
John S SampalisJSS Medical Research Inc., St-Laurent, QC, Canada.
Kelly D JohnsonCenter for Observational & Real-World Evidence, Vaccines, Merck & Co., Inc., Kenilworth, NJ, United States.
Homero A MonsantoCenter for Observational & Real-World Evidence, Latin America, MSD (IA) LLC, Carolina, Puerto Rico.
Camilo J AcostaCenter for Observational & Real-World Evidence, Vaccines, Merck & Co., Inc., Kenilworth, NJ, United States.
Merck & Co., Inc., Rahway, NJ, USA (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesHerpes zoster is characterized by acute neuritis and post-herpetic neuralgia. Currently, data concerning the zoster-associated impact on quality of life and healthcare resource utilization in Brazil are scarce. This study measured the zoster-associated burden in a Brazilian population.

methodsThis was a prospective, observational, single-cohort study conducted in a primary hospital's emergency room in São Paulo, Brazil. Patients enrolled at various timepoints during a zoster episode were followed over 180 days. The Zoster Brief Pain Inventory and the Initial Zoster Impact Questionnaire assessed zoster-associated pain. The EuroQoL assessed the impact of herpes zoster and/or zoster-associated pain on quality of life. Healthcare resource utilization was assessed by patient-reported questionnaires.

resultsOne-hundred forty-six zoster patients were enrolled [mean (SD) age of 69.9 (10.9) years]. Mean (SD) worst pain scores decreased from 5.3 (3.5) at baseline to 1.9 (3.0) 180 days following rash onset. Mean (SD) EuroQoL scores significantly decreased from 0.9 (0.2) before rash appearance to 0.7 (0.2) after rash onset (p<0.001), followed by gradual improvements in quality of life over 180 days, with pre-herpes zoster quality of life achieved at the end of the observation period. The majority of patients purchased prescription medications (89.7%) and required doctor's office visits (65.8%) for zoster episodes.

conclusionsHerpes zoster is associated with a significant disease burden, including zoster-associated pain, impaired quality of life and increased healthcare resource utilization in Brazil. These results support the implementation of early intervention and prevention programs such as vaccinations to reduce the herpes zoster-associated disease burden in Brazil.

Indexed as

Quality of LifeSickness Impact ProfileAgedAge DistributionBrazilCost of IllnessFemaleHerpes ZosterHumansMaleMiddle AgedNeuralgia, PostherpeticProspective StudiesSeverity of Illness IndexSex DistributionSocioeconomic Factors

Identifiers

PMID30043824
PMCPMC6044137
OpenAlexW2884145544

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.